Actively Recruiting
Carotid Intraplaque Neovascularization Combined With Stress Echo
Led by Dr. Amer Johri · Updated on 2025-02-06
1500
Participants Needed
6
Research Sites
260 weeks
Total Duration
On this page
Sponsors
D
Dr. Amer Johri
Lead Sponsor
L
Lantheus Medical Imaging
Collaborating Sponsor
AI-Summary
What this Trial Is About
The root cause of heart attacks and strokes is atherosclerosis, the hardening and thickening of blood vessels due to the presence of "plaque" which is a build-up of fat and cholesterol in the walls of vessels. To diagnose heart disease, patients receive a stress test to find out if they require surgery. Up to 52% of patients receiving an angiogram (surgery) to look at plaque blockages in the heart are found to be normal (no blockage). Patients who are suspected of having heart disease often undergo a stress test, which helps cardiologists decide if the patient has heart disease, but stress tests can give false results. In Ontario alone, 90% are stress tests are found to be normal and patients are sent home with little follow-up. Of these 3-5% (\~4,000 patients/year) will have a major cardiovascular event (heart attack, surgery, or death) within 3 years. We need to improve the stress test accuracy to reduce cardiac outcome. We now know that it is not just the total amount of plaque that leads to heart attacks and strokes, but the composition of the plaque that can lead to breakage causing a heart attack. Plaques are soft and fragile, and typically contain fat and small leaky blood vessels within their cores. If we are able to identify patients that have leaky plaques using ultrasound, we may be able to improve the accuracy of stress testing. We propose a study looking at the combination of stress testing (assessing heart function) and neck ultrasound (assessing plaque composition), to identify patients at risk for cardiovascular events (heart attacks and death). We will enrol patients from 6 sites across Canada and follow-them for cardiac outcome for 3 years.
CONDITIONS
Official Title
Carotid Intraplaque Neovascularization Combined With Stress Echo
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women older than 18 years
- Referred for a clinically indicated stress echocardiography for ischemia and risk assessment
- Able and willing to provide informed consent
You will not qualify if you...
- Emergency procedures or active acute coronary syndrome symptoms
- Referral for viability, pulmonary hypertension, or valve assessment
- Referral outside normal working hours
- History of significant coronary artery disease procedures (PCI, coronary artery bypass graft, or angioplasty)
- History of stroke or myocardial infarction
- Known allergy to perflutren contrast agent or Polyethylene Glycol (component of the contrast agent)
- History of carotid artery surgery (endarterectomy or stenting)
- Serious medical conditions or complications that could interfere with the carotid scan or care
- Currently pregnant or breastfeeding
- Previously enrolled in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
University of Calgary
Calgary, Alberta, Canada, T2N 1N4
Actively Recruiting
2
University of Alberta
Edmonton, Alberta, Canada, T6G 2R3
Not Yet Recruiting
3
Dalhousie University
Halifax, Nova Scotia, Canada, B3H 3A7
Actively Recruiting
4
The Kingston Heart Clinic
Kingston, Ontario, Canada, K7L 1C2
Actively Recruiting
5
Queen's University, Cardiovascular Imaging Network at Queen's (CINQ)
Kingston, Ontario, Canada, K7L 2V7
Actively Recruiting
6
Unity Health Toronto
Toronto, Ontario, Canada, M5B 1W8
Actively Recruiting
Research Team
M
Marie-France Hetu, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here